Stocks rose this morning after a better-than-expected jobs report.
The U.S. economy added 255,000 jobs last month, well above the 180,000 that had been expected. The unemployment rate was unchanged at 4.9%.
The trade gap grew by a larger-than-anticipated 8.7% in June from the previous month as import rose by 1.9% and exports gained 0.3%.
Stocks on the Move
Bristol (BMY) announced negative top-line trial results for key cancer drug Opdivo in lung cancer that will likely reduce the drug’s potential share in immuno-oncology with Merck’s (MRK) Keytruda gaining share. Bristol shares sank more than 15% on the report while Merck gained over 7%.
Jeremy Glaser does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.